Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 20, 2012
Fibrinolytic system in preeclampsiaM B Pinheiro, K B Gomes, L M S Dusse
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 18, 2015
Leptin in Alzheimer's diseaseC A Magalhães, M G Carvalho, L P Sousa, et al.
Journal of Inherited Metabolic Disease|January 26, 2006
Phenotypic heterogeneity in biochemical parameters correlates with mutations in AGPAT2 or Seipin genes among Berardinelli-Seip congenital lipodystrophy patientsK B Gomes, V Cavalcanti Pardini, A Clayton de Souza Ferreira, et al.
Annals of Human Genetics|May 31, 2007
Founder effect of the 669insA mutation in BSCL2 gene causing Berardinelli-Seip congenital lipodystrophy in a cluster from BrazilK B Gomes, V C Pardini, A C S Ferreira, et al.
Genetics and Molecular Research : GMR|August 15, 2009
Frequency of the S65C mutation in the hemochromatosis gene in BrazilV C Oliveira, F A Caxito, K B Gomes, et al.
Genetics and Molecular Research : GMR|October 31, 2009
Lack of association of C282Y and H63D mutations in the hemochromatosis (HFE) gene with diabetes mellitus type 2 in a case-control study of women in BrazilK B Gomes, M G Carvalho, F F Coelho, et al.
Journal of Diabetes Research|June 12, 2015
Association of a Large Panel of Cytokine Gene Polymorphisms with Complications and Comorbidities in Type 2 Diabetes PatientsK F Rodrigues, N T Pietrani, V C Sandrim, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 17, 2011
Association of apoliprotein E polymorphisms and metabolic syndrome in subjects with extreme obesityD C Ferreira, T F Costa, S L F Aguiar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2009
D-dimer as a possible prognostic marker of operable hormone receptor-negative breast cancerA P B Batschauer, C P Figueiredo, E C Bueno, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|August 1, 2013
Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymorphism and metabolic/proinflammatory factors in polycystic ovary syndromeM F Sales, M O Sóter, A L Candido, et al.
Pageof 2